Cargando…

Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway

BACKGROUND: AMPD2 is a critical enzyme catalyzing smooth muscle energy supply and metabolism; however, its cellular biological function and clinical implication in colorectal cancer (CRC) are largely unknown. AIM: To clarify the role of AMPD2 in CRC and study the pathway and prognostic value of its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qi-Zhong, Qin, Yan, Wang, Wei-Jia, Fei, Bo-Jian, Han, Wei-Feng, Jin, Jian-Qiang, Gao, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Clinical and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441253/ https://www.ncbi.nlm.nih.gov/pubmed/32874974 http://dx.doi.org/10.12998/wjcc.v8.i15.3197

Ejemplares similares

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis
por: Sun, Jian, et al.
Publicado: (2016)

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
por: Nagata, M, et al.
Publicado: (2011)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
por: Mokutani, Yukako, et al.
Publicado: (2016)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

Overexpression of CASC19 indicates poor prognosis and facilitates proliferation, migration and invasion in colorectal cancer
por: Zhao, Jiang, et al.
Publicado: (2019)

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
por: Luo, Yang, et al.
Publicado: (2015)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015)

Overexpression of the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1 is associated with the poor prognosis of patients with colorectal cancer
por: Gao, Chang, et al.
Publicado: (2018)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Ma, Wei, et al.
Publicado: (2022)

High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer
por: Yang, Shan, et al.
Publicado: (2023)

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
por: Liu, Zhaoxia, et al.
Publicado: (2016)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
por: Kumar, S R, et al.
Publicado: (2007)

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival
por: Kucia-Tran, Justyna A, et al.
Publicado: (2016)

Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
por: Cabalag, Carlos S., et al.
Publicado: (2022)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
por: Zhao, Jingkun, et al.
Publicado: (2017)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer
por: Han, Qiang, et al.
Publicado: (2019)

Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2
por: Gao, Wei, et al.
Publicado: (2013)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
por: Fiaschetti, G, et al.
Publicado: (2014)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis
por: Li, Yiming, et al.
Publicado: (2017)

Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients
por: Li, Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hfgt8gdeg4bu5qvmee89guf2dk